-- Mary Elizabeth Dallas
TUESDAY, May 21 (HealthDay News) -- Racial disparities exist in
the treatment of non-small cell lung cancer among hospitals in the
United States, according to a large new study.
Although most patients with this condition undergo surgery as
part of their initial treatment, researchers found that blacks were
less likely than Hispanics or whites to have surgery in the early
stages of the disease. Hispanics were more likely to undergo
surgery for stage 1 and stage 2 disease than white patients.
"In our study of more than 1.2 million patients diagnosed with [non-small cell lung cancer] in U.S. hospitals between the years 2000 and 2010, we found statistically significant racial disparities in the surgical management of these patients," researcher Jayanth Adusumalli said in an American Thoracic Society news release.
Up to 90 percent of lung cancers are non-small cell, according
to the American Cancer Society.
The new study involved 1.2 million patients from a national
cancer database, about 975,000 of whom received their initial
treatment following a diagnosis of non-small cell lung cancer.
Eighty-two percent of white patients received treatment, as well as
79 percent of black patients and 76 percent of Hispanics.
However, 82 percent of Hispanics and 78 percent of whites with
stage 1 disease underwent surgery, compared to 73 percent of blacks
who had surgery as their initial form of treatment. For patients
with stage 2 disease, 67 percent of Hispanics, 64 percent of whites
and 56 percent of blacks had surgery.
The study was scheduled for Tuesday presentation at the annual
meeting of the American Thoracic Society in Philadelphia. The data
and conclusions should be viewed as preliminary until published in
a peer-reviewed journal.
"The significant racial differences in the initial treatment of [non-small cell lung cancer] that we found in our study may contribute to the recognized racial disparities in cancer patient outcomes," said Adusumalli, of the Creighton University Medical Center in Omaha, Neb. "Further research into the underlying causes of these treatment disparities may help improve the treatment and prognosis of all lung cancer patients."
The U.S. National Institutes of Health has more about
racial disparities in health care.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.